Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 - Jones, S; Holmes, F A; OʼShaughnessy, J (J Clin Oncol, 2009)